A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)
Clinical trial NCT06990984 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06990984
- Sponsor
- Thiogenesis Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.